The luteolytic effect of the GnRH antagonist has been proposed as the main theory to explain the mode of action of these drugs to prevent OHSS (59), although the normal luteal phase of the donors in this study does not support this idea. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.